Income Statement Zhejiang Jolly Pharmaceutical Co.,LTD

Equities

300181

CNE100001096

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
12.32 ^CNY	+0.08%		-4.20%	+15.57%

Jul. 29	Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2024	CI
Jul. 29	Zhejiang Jolly Pharmaceutical Co.,LTD announces an Equity Buyback for CNY 300 million worth of its shares.	CI

feec3a73.55UloOo_KdIpNcNvkQpRqbXUyW-lyuOxePfwZiQywv0.ivZJ5IltWrBAXbBe_2ca_YDjlj_cnNLFDJCSV35xt87X9k_ohg9mmmdTig

Published financial data: ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	907M	1.09B	1.45B	1.79B	1.94B
Other Revenues, Total	4.15M	5.32M	7.26M	18.23M	5.2M
Total Revenues	911M	1.09B	1.46B	1.81B	1.94B
Cost of Goods Sold, Total	330M	363M	420M	535M	616M
Gross Profit	581M	728M	1.04B	1.27B	1.33B
Selling General & Admin Expenses, Total	528M	601M	794M	921M	874M
Provision for Bad Debts	1.81M	588K	1.2M	5.24M	846K
R&D Expenses	27.16M	30.39M	45.63M	64.43M	79.38M
Other Operating Expenses	-22.93M	-21.62M	-28.31M	-42.32M	-49.99M
Other Operating Expenses, Total	534M	611M	813M	949M	904M
Operating Income	47.57M	117M	224M	322M	422M
Interest Expense, Total	-22.81M	-17.93M	-12.07M	-8.32M	-7.62M
Interest And Investment Income	6.89M	2.05M	4.41M	4.64M	22M
Net Interest Expenses	-15.92M	-15.88M	-7.66M	-3.68M	14.37M
Currency Exchange Gains (Loss)	-237K	-	-	-154	114
Other Non Operating Income (Expenses)	1.59M	2.13M	-1.13M	-13.81K	179K
EBT, Excl. Unusual Items	33M	104M	215M	318M	436M
Impairment of Goodwill	-10.27M	-	-	-	-
Gain (Loss) On Sale Of Investments	-1.29M	385K	518K	78.08K	-101K
Gain (Loss) On Sale Of Assets	1.33M	-75.93K	-1.92M	-9.71M	-247K
Asset Writedown	-39.86K	-	-	-	-
Other Unusual Items	6.43M	5.17M	8.24M	15.74M	10.78M
EBT, Incl. Unusual Items	29.16M	109M	222M	324M	447M
Income Tax Expense	5.27M	13.87M	30.33M	38.6M	55.88M
Earnings From Continuing Operations	23.89M	95.31M	192M	286M	391M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	23.89M	95.31M	192M	286M	391M
Minority Interest	1.7M	-6.51M	-12.58M	-12.51M	-7.83M
Net Income - (IS)	25.59M	88.8M	179M	273M	383M
Net Income to Common Incl Extra Items	25.59M	88.8M	179M	273M	383M
Net Income to Common Excl. Extra Items	25.59M	88.8M	179M	273M	383M
Per Share Items
Net EPS - Basic	0.04	0.15	0.29	0.45	0.55
Basic EPS - Continuing Operations	0.04	0.15	0.29	0.45	0.55
Basic Weighted Average Shares Outstanding	608M	609M	609M	607M	696M
Net EPS - Diluted	0.04	0.15	0.29	0.45	0.55
Diluted EPS - Continuing Operations	0.04	0.15	0.29	0.45	0.55
Diluted Weighted Average Shares Outstanding	608M	609M	609M	607M	696M
Normalized Basic EPS	0.04	0.1	0.2	0.31	0.38
Normalized Diluted EPS	0.04	0.1	0.2	0.31	0.38
Dividend Per Share	0.02	0.1	0.2	0.3	0.45
Payout Ratio	270.23	34.8	39.17	53.17	57.44
Supplemental Items
EBITDA	95.45M	171M	277M	378M	482M
EBITA	52.77M	122M	228M	325M	425M
EBIT	47.57M	117M	224M	322M	422M
EBITDAR	97.07M	172M	280M	379M	485M
Total Revenues (As Reported)	911M	1.09B	1.46B	1.81B	1.94B
Effective Tax Rate - (Ratio)	18.07	12.71	13.64	11.91	12.51
Current Domestic Taxes	8.68M	19.32M	33.81M	41.51M	57.63M
Total Current Taxes	8.68M	19.32M	33.81M	41.51M	57.63M
Deferred Domestic Taxes	-3.41M	-5.45M	-3.48M	-2.9M	-1.75M
Total Deferred Taxes	-3.41M	-5.45M	-3.48M	-2.9M	-1.75M
Normalized Net Income	22.33M	58.31M	122M	186M	265M
Interest on Long-Term Debt	-	-	1.32M	1.34M	845K
Non-Cash Pension Expense	653K	218K	196K	212K	1.13M
Supplemental Operating Expense Items
Advertising Expense	6.01M	7.02M	528M	675M	619M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	446M	518M	708M	831M	777M
General and Administrative Expenses	81.19M	83.56M	85.76M	90.58M	96.69M
Research And Development Expense From Footnotes	27.93M	31.24M	45.63M	64.43M	79.38M
Net Rental Expense, Total	1.62M	1.62M	2.91M	859K	2.75M
Imputed Operating Lease Interest Expense	740K	659K	1.01M	301K	847K
Imputed Operating Lease Depreciation	878K	959K	1.9M	558K	1.9M
Maintenance & Repair Expenses, Total	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	138M	254M	232M	1.08B	932M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	300K	61.04M	65.52M	10.83M	151M
Total Cash And Short Term Investments	139M	315M	298M	1.09B	1.08B
Accounts Receivable, Total	311M	308M	337M	510M	532M
Other Receivables	27.5M	5.9M	26.77M	24.42M	9.02M
Total Receivables	338M	314M	364M	534M	541M
Inventory	201M	201M	274M	319M	427M
Prepaid Expenses	-	-	-	7.87M	-
Other Current Assets, Total	12.71M	135M	6.16M	5.45M	5.53M
Total Current Assets	691M	965M	942M	1.96B	2.06B
Gross Property Plant And Equipment	1.06B	1.06B	1.16B	1.37B	1.52B
Accumulated Depreciation	-258M	-306M	-356M	-402M	-459M
Net Property Plant And Equipment	799M	750M	806M	972M	1.06B
Long-term Investments	228M	463M	651M	392M	180M
Goodwill	130M	130M	130M	130M	130M
Other Intangibles, Total	74.9M	70.2M	64.89M	63.04M	71.27M
Deferred Tax Assets Long-Term	8.9M	14.41M	15.51M	21.27M	25.5M
Deferred Charges Long-Term	24.72M	23.11M	25.6M	25.42M	25.49M
Other Long-Term Assets, Total	93.71M	53.37M	114M	74.76M	78.07M
Total Assets	2.05B	2.47B	2.75B	3.64B	3.63B
Liabilities
Accounts Payable, Total	181M	201M	297M	469M	434M
Accrued Expenses, Total	41.42M	49.87M	62.33M	78.32M	82.24M
Short-term Borrowings	217M	303M	178M	138M	193M
Current Portion of Long-Term Debt	51.5M	15M	-	-	10.01M
Current Portion of Leases	-	-	4.21M	2.84M	2.49M
Current Income Taxes Payable	2.39M	7.3M	16.46M	26.59M	32.65M
Unearned Revenue Current, Total	-	1.56M	3.06M	14.14M	2.23M
Other Current Liabilities	18.92M	21.83M	23.55M	26M	38.28M
Total Current Liabilities	512M	599M	585M	755M	795M
Long-Term Debt	88.13M	30.05M	-	10M	-
Long-Term Leases	-	-	24.27M	22.13M	16.69M
Unearned Revenue Non Current	26.33M	25.48M	22.37M	19.76M	19.9M
Deferred Tax Liability Non Current	15.99M	95.86M	134M	72.36M	21.68M
Total Liabilities	643M	750M	765M	879M	853M
Common Stock, Total	609M	609M	609M	701M	701M
Additional Paid In Capital	340M	340M	340M	1.14B	1.14B
Retained Earnings	320M	396M	526M	677M	849M
Comprehensive Income and Other	41.89M	258M	369M	190M	42.66M
Total Common Equity	1.31B	1.6B	1.84B	2.7B	2.73B
Minority Interest	97.43M	117M	139M	56.18M	45.2M
Total Equity	1.41B	1.72B	1.98B	2.76B	2.77B
Total Liabilities And Equity	2.05B	2.47B	2.75B	3.64B	3.63B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	609M	609M	609M	701M	701M
ECS Total Common Shares Outstanding	609M	609M	609M	701M	701M
Book Value / Share	2.15	2.63	3.03	3.85	3.89
Tangible Book Value	1.11B	1.4B	1.65B	2.51B	2.53B
Tangible Book Value Per Share	1.82	2.3	2.71	3.58	3.6
Total Debt	356M	348M	207M	173M	222M
Net Debt	218M	33.11M	-91.15M	-920M	-861M
Debt Equivalent Oper. Leases	12.95M	12.95M	23.28M	6.87M	21.98M
Minority Interest, Total (Incl. Fin. Div)	97.43M	117M	139M	56.18M	45.2M
Equity Method Investments, Total	62.1M	1.66M	1.8M	1.87M	1.85M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	56.85M	74.5M	92.06M	129M	165M
Inventories - Work In Process, Total	19.86M	18.19M	37.48M	58.51M	59.07M
Inventories - Finished Goods, Total	143M	115M	148M	135M	207M
Buildings, Total	669M	657M	678M	833M	963M
Machinery, Total	317M	399M	413M	433M	468M
Full Time Employees	1.77K	1.99K	2.13K	2.46K	2.69K
Assets on Operating Lease - Gross	-	-	-	-	-
Assets on Operating Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	9.04M	9.47M	10.46M	15.31M	15.92M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	25.59M	88.8M	179M	273M	383M
Depreciation & Amortization - CF	42.68M	48.56M	53.23M	56.97M	60.99M
Amortization of Goodwill and Intangible Assets - (CF)	5.2M	4.73M	3.3M	2.81M	3.04M
Depreciation & Amortization, Total	47.87M	53.3M	56.53M	59.78M	64.03M
Amortization of Deferred Charges, Total - (CF)	2.75M	3.07M	3.11M	4.09M	4.47M
(Gain) Loss From Sale Of Asset	-1.33M	75.93K	-242K	-1.72M	-279K
(Gain) Loss on Sale of Investments - (CF)	121K	-385K	-1.72M	-1.48M	101K
Asset Writedown & Restructuring Costs	10.31M	-	2.16M	11.44M	526K
Provision and Write-off of Bad Debts	1.81M	588K	1.2M	5.24M	846K
Other Operating Activities, Total	32.23M	34.75M	28.39M	24.26M	18.18M
Change In Accounts Receivable	-38.51M	18.28M	-60.91M	-208M	-27.64M
Change In Inventories	26.87M	-12.83M	-76.15M	-61.54M	-99.15M
Change In Accounts Payable	24.63M	19.68M	127M	216M	-53.81M
Change In Deferred Taxes	-3.41M	74.35M	-7.08M	-2.9M	-1.75M
Cash from Operations	129M	280M	252M	319M	288M
Capital Expenditure	-40.46M	-58.35M	-148M	-178M	-132M
Sale of Property, Plant, and Equipment	3.22M	3.22M	104K	5.87M	2.43M
Cash Acquisitions	-	-	-	-	-
Divestitures	4M	4.08M	-	-	-
Investment in Marketable and Equity Securities, Total	39.76M	-70.73M	103M	54.25M	-140M
Other Investing Activities, Total	8.6M	529K	7.76M	4.58M	5.95M
Cash from Investing	15.13M	-121M	-36.89M	-113M	-264M
Long-Term Debt Issued, Total	350M	308M	237M	252M	260M
Total Debt Issued	350M	308M	237M	252M	260M
Long-Term Debt Repaid, Total	-452M	-316M	-411M	-286M	-209M
Total Debt Repaid	-452M	-316M	-411M	-286M	-209M
Issuance of Common Stock	-	-	-	898M	-
Common Dividends Paid	-69.16M	-30.9M	-70.28M	-145M	-220M
Common & Preferred Stock Dividends Paid	-69.16M	-30.9M	-70.28M	-145M	-220M
Other Financing Activities, Total	-54.77M	-13.67M	1.15M	-75.98M	9.72M
Cash from Financing	-227M	-53.08M	-243M	643M	-159M
Foreign Exchange Rate Adjustments	-	-	-	-154	114
Net Change in Cash	-82.46M	105M	-28.04M	848M	-134M
Supplemental Items
Cash Interest Paid	17.67K	-	-	101K	114K
Cash Income Tax Paid (Refund)	64.39M	77.65M	174M	198M	226M
Levered Free Cash Flow	126M	-1.06M	172M	70.68M	64.03M
Unlevered Free Cash Flow	140M	10.14M	180M	75.88M	68.79M
Change In Net Working Capital	-99.93M	61.28M	-128M	11.02M	132M
Net Debt Issued / Repaid	-103M	-8.5M	-174M	-33.9M	50.91M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	1.43	3.25	5.37	6.3	7.25
Return on Total Capital	1.66	3.83	6.58	7.85	8.89
Return On Equity %	1.71	6.1	10.37	12.04	14.12
Return on Common Equity	1.97	6.1	10.41	12.01	14.1
Margin Analysis
Gross Profit Margin %	63.79	66.73	71.16	70.38	68.27
SG&A Margin	57.91	55.11	54.5	51.05	45
EBITDA Margin %	10.48	15.65	19.02	20.92	24.83
EBITA Margin %	5.79	11.2	15.61	17.98	21.86
EBIT Margin %	5.22	10.77	15.39	17.82	21.71
Income From Continuing Operations Margin %	2.62	8.74	13.17	15.82	20.12
Net Income Margin %	2.81	8.14	12.31	15.12	19.71
Net Avail. For Common Margin %	2.81	8.14	12.31	15.12	19.71
Normalized Net Income Margin	2.45	5.34	8.38	10.32	13.63
Levered Free Cash Flow Margin	13.78	-0.1	11.8	3.92	3.3
Unlevered Free Cash Flow Margin	15.35	0.93	12.32	4.2	3.54
Ass